The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation
Sakis Themistoclakis(Texas Cardiac Arrhythmia), Andrea Natale(Texas Cardiac Arrhythmia), Andrea Corrado(Università Cattolica del Sacro Cuore), David J. Callans(University of Pennsylvania), Luigi Di Biase(Albert Einstein College of Medicine), Rodney Horton(Texas Cardiac Arrhythmia), Aldo Bonso(Ospedali Riuniti Umberto I), Prasant Mohanty(Texas Cardiac Arrhythmia), Antonio Rossillo(Texas Cardiac Arrhythmia), Walid I. Saliba(Cleveland Clinic), Francis E. Marchlinski(University of Pennsylvania), Pierre Jaı̈s(Université de Bordeaux), Oussama M. Wazni(Cleveland Clinic), Michel Haı̈ssaguerre(Université de Bordeaux), Dimpi Patel(Texas Cardiac Arrhythmia), Robert A. Schweikert(Texas Cardiac Arrhythmia), Erica S. Zado(California University of Pennsylvania), David Burkhardt(California Pacific Medical Center), Antonio Raviele(Atrial Fibrillation NETwork)
Cited by 277
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins
|Circulation|2000|966
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
|Circulation|2008|887